Merck no-go decision spells the end for JT's novel osteoporosis drug
18 October 2011
Ian Haydock
Please Login to read the full article.
18 October 2011
Ian Haydock
ian.haydock@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Ibandronate set for filing in Japan following positive local trial
- CETP arena sees another major casuality as Roche drops dalcetrapib
- Amgen buys KAI Pharma for $315M to extend franchise in secondary hyperparathyroidism
- Asahi Kasei eyes convenience benefits in Zosano transdermal teriparatide deal
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
